BRPI0510717B8 - uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr) - Google Patents

uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr)

Info

Publication number
BRPI0510717B8
BRPI0510717B8 BRPI0510717A BRPI0510717A BRPI0510717B8 BR PI0510717 B8 BRPI0510717 B8 BR PI0510717B8 BR PI0510717 A BRPI0510717 A BR PI0510717A BR PI0510717 A BRPI0510717 A BR PI0510717A BR PI0510717 B8 BRPI0510717 B8 BR PI0510717B8
Authority
BR
Brazil
Prior art keywords
diindolylmethane
dim
ltr
indol
ylmethyl
Prior art date
Application number
BRPI0510717A
Other languages
English (en)
Inventor
A Zeligs Michael
Original Assignee
Bioresponse Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresponse Llc filed Critical Bioresponse Llc
Publication of BRPI0510717A publication Critical patent/BRPI0510717A/pt
Publication of BRPI0510717B1 publication Critical patent/BRPI0510717B1/pt
Publication of BRPI0510717B8 publication Critical patent/BRPI0510717B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

uso de 3,3 diindolilmetano (dim) ou um indol relacionado com dim. a presente invenção diz respeito a composições e métodos para tratar ou prevenir leiomiomas pela administração de diindolilmetano e indóis relacionados com diindolilmetano. a presente invenção também diz respeito a composições e métodos para tratar ou prevenir leiomiomas pela administração de diindolilmetano em combinação com um antagonista de egfr. os métodos fornecem tratamentos não invasivos para leiomiomas.
BRPI0510717A 2004-05-06 2005-05-06 uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr) BRPI0510717B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56947804P 2004-05-06 2004-05-06
US60/569,478 2004-05-06
PCT/US2005/015876 WO2005107747A2 (en) 2004-05-06 2005-05-06 Diindolymethane formulations for the treatment of leiomyomas

Publications (3)

Publication Number Publication Date
BRPI0510717A BRPI0510717A (pt) 2007-11-20
BRPI0510717B1 BRPI0510717B1 (pt) 2019-10-01
BRPI0510717B8 true BRPI0510717B8 (pt) 2021-05-25

Family

ID=35320724

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510717A BRPI0510717B8 (pt) 2004-05-06 2005-05-06 uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr)

Country Status (4)

Country Link
US (1) US8080577B2 (pt)
BR (1) BRPI0510717B8 (pt)
CA (1) CA2565721C (pt)
WO (1) WO2005107747A2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006019831A1 (en) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
JP2008524221A (ja) * 2004-12-17 2008-07-10 バイオノボ・インコーポレーテッド Ｅｐｉｍｅｄｉｕｍ属植物の抽出液を用いた方法
ATE497762T1 (de) 2004-12-30 2011-02-15 Bioresponse Llc Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US8586621B2 (en) 2006-10-27 2013-11-19 Michael A. Zeligs Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
US20080187925A1 (en) * 2006-10-30 2008-08-07 The Board Of Regents Of The University Of Nebraska Biomarkers of Cancer Risk and Their Use in Cancer Detection and Prevention
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
WO2009021196A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of ligustrum lucidum and uses thereof
JP2010539085A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
JP2010539086A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
WO2009033025A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
US9155770B2 (en) * 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
US20090118301A1 (en) * 2007-11-02 2009-05-07 Arbor Vita Corporation Compositions and Methods for Treating Cancer
EP2219659A4 (en) * 2007-11-19 2010-11-17 Bionovo Inc METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT
CA2706330A1 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
EP2222321A4 (en) * 2007-11-19 2013-02-13 Bionovo Inc THERAPY AGAINST CANCER WITH AN EXTRACT OF SCUTELLARIA BARBATA
US20090130118A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
US20090258942A1 (en) * 2008-04-14 2009-10-15 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
EP2310024A4 (en) * 2008-05-06 2012-07-25 Bionovo Inc ESTROGENIC EXTRACTS FOR THE TREATMENT OF VAGINA AND VULVAATROPHY
EP2294402A2 (en) * 2008-06-05 2011-03-16 Bionovo Inc. Method of quantification of multiple bioactives from botanical compositons
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
EP2340027A4 (en) * 2008-09-03 2012-04-04 Bionovo Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
DE202008012041U1 (de) 2008-09-10 2008-11-27 Kisselew, Wsewolod Iwanowitsch Vaginalzäpfchen auf Basis von 3,3'-Dindolylmethan (Methindol)
US20100303936A1 (en) * 2009-04-28 2010-12-02 Bionovo, Inc. A Delaware Corporation Method of reducing fat accumulation and inducing weight loss
RU2409363C9 (ru) * 2009-09-18 2013-12-10 Всеволод Иванович Киселев Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций
EP3280398B1 (en) 2015-04-10 2026-02-25 Bioresponse LLC Self-emulsifying formulations of dim-related indoles
RU2018134115A (ru) * 2016-05-16 2020-06-17 Акционерное общество "ВЕЛЕС ФАРМА" Средства для лечения инфекционных заболеваний, передаваемых половым путём
CN106565587B (zh) * 2016-11-11 2018-11-09 南京大学 一种aurkb小分子抑制剂及其应用
EP4157271A1 (en) 2020-05-29 2023-04-05 Boulder Bioscience LLC Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
CA3268510A1 (en) 2022-09-30 2024-04-04 Boulder Bioscience Llc Compositions containing 3,3'-diindolmythane for treating a closed, non-bleeding head wound

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718921A (en) 1987-03-13 1998-02-17 Massachusetts Institute Of Technology Microspheres comprising polymer and drug dispersed there within
FR2676927B1 (fr) 1991-05-29 1995-06-23 Ibf Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant.
GB9300059D0 (en) 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
EP0656786B2 (en) 1992-05-19 2014-04-23 Novogen Research Pty Ltd Use of isoflavone phyto-oestrogen extracts of soy or clover
DE69536015D1 (de) 1995-03-30 2009-12-10 Pfizer Prod Inc Chinazolinone Derivate
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
SI9620103A (sl) 1995-07-06 1998-10-31 Novartis Ag Pirolopirimidini in postopki za njihovo pripravo
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
EA001595B1 (ru) 1996-04-12 2001-06-25 Варнер-Ламберт Компани Необратимые ингибиторы тирозинкиназ
US5948808A (en) * 1997-03-07 1999-09-07 The Texas A&M University System Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
EP0969868A2 (en) 1997-03-18 2000-01-12 Ortho-Mcneil Pharmaceutical, Inc. Methods and kits for treating and diagnosing leiomyomas
US6150395A (en) * 1997-05-30 2000-11-21 The Regents Of The University Of California Indole-3-carbinol (I3C) derivatives and methods
US5895787A (en) 1997-10-08 1999-04-20 Designed Nutritional Products, Inc. Treatment of fibromyalgia and related disorders
WO1999020647A1 (fr) * 1997-10-17 1999-04-29 Mochida Pharmaceutical Co., Ltd. Remede contre les hysteromyomes, contenant du dienogeste comme principe actif
US6086915A (en) 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
JP4652569B2 (ja) 1998-04-29 2011-03-16 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド Ｎ−（３−エチニルフェニルアミノ）−６，７−ビス（２−メトキシエトキシ）−４−キナゾリンアミンメシレートの無水物及び一水和物
EA003786B1 (ru) 1998-11-19 2003-10-30 Варнер Ламберт Компани N-[4-(3-хлор-4-фторфениламино)-7-(3-морфолин-4-илпропокси)хиназолин-6-ил]акриламид - необратимый ингибитор тирозинкиназ
US6613792B1 (en) 1999-08-02 2003-09-02 Designed Nutritional Products, Inc. Treatment of premenstrual syndrome and menopause
US6689387B1 (en) 1999-09-23 2004-02-10 Bioresponse Llc Phytochemicals for treatment of mastalgia and endometriosis
US6534085B1 (en) 1999-09-23 2003-03-18 Bioresponse L.L.C. Phytochemicals for promoting weight loss
US7384971B2 (en) 1999-09-23 2008-06-10 Bioresponse L.L.C. Phytochemicals for the treatment of cervical dysplasia
EP1263803B1 (en) 2000-03-13 2007-09-19 BioCure, Inc. Embolic compositions
US6399645B1 (en) * 2000-03-20 2002-06-04 Maria Bell Chemoprevention and treatment of cervical or vaginal neoplasia
DE01918975T1 (de) 2000-03-24 2006-04-13 Biosphere Medical, Inc., Rockland Mikrokügelchen zur aktiven Embolisierung
US6477229B1 (en) 2000-05-12 2002-11-05 Siemens Medical Solutions Usa, Inc. Radiation therapy planning
US7709520B2 (en) * 2000-10-06 2010-05-04 The Texas A&M University System Diindolylmethane and C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
US20020147155A1 (en) 2001-04-06 2002-10-10 Foster Warren G. Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
US7348352B2 (en) 2001-10-23 2008-03-25 Bioresponse L.L.C. Diindolylmethane for the treatment of HPV infection
US20030220377A1 (en) 2002-05-08 2003-11-27 Richard Chesworth Indole compounds and their use as estrogen agonists/antagonists
US6800655B2 (en) 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

Also Published As

Publication number Publication date
WO2005107747A2 (en) 2005-11-17
US20050267193A1 (en) 2005-12-01
WO2005107747A3 (en) 2007-01-11
CA2565721C (en) 2015-10-06
BRPI0510717B1 (pt) 2019-10-01
US8080577B2 (en) 2011-12-20
BRPI0510717A (pt) 2007-11-20
CA2565721A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
BRPI0510717B8 (pt) uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr)
EA200970190A1 (ru) Соединения индола
CR7056A (es) Derivados de 3-(4-amidopirrol-2-ilmetilden)-2-indolinona como inhibidores de la protein quinasa
MY207663A (en) Substituted indoles and methods of use thereof
MXPA05010174A (es) Derivados de indol e indolina sustituidos.
SG155188A1 (en) Pyrrole derivatives as pharmaceutical agents
EA200301215A1 (ru) Лиганды рецепторов 5-ht и их применение
CY1113734T1 (el) Χημικες ενωσεις
DK1558616T4 (da) Meso-substituerede porphyriner
NO20082880L (no) Inhibitorer av C-MET samt anvendelse derav
ATE340794T1 (de) Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
MA31150B1 (fr) Antagonistes spécifiques de vegf pour thérapie par adjuvant et néoadjuvant et traitement de tumeurs de premier stade
BR0215360A (pt) Derivados de indolina úteis como inibidores de proteìna quinase
EA200701357A1 (ru) Композиции и способы применения модулятора рецептора 5ht
EA200300183A1 (ru) Новое сочетание агониста (5-th2) и антагониста (5-ht6) серотонина в качестве фармацевтической композиции
DE60138605D1 (de) Phenyl-substituierte indole als h3 histaminrezeptorantagonisten
EA200701853A1 (ru) Производные циклопентапиридина и тетрагидрохинолина
SG164283A1 (en) New benzimidazole derivatives
DE60312226D1 (de) Tetrazyklische 3-substituierte indole mit serotoninrezeptoraffinität
DE60307856D1 (de) Antitumorverbindung und ihre therapeutischen verwendungen
BR0311593A (pt) Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc
WO2008021891A3 (en) Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
EA200970875A1 (ru) Производные индолизинуксусной кислоты в качестве антагонистов crth2
ATE399777T1 (de) Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors
WO2003072558A3 (en) Arylsulfone derivatives

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/10/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/05/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25G Requested change of headquarter approved

Owner name: BIORESPONSE, LLC (US)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2773 DE 27-02-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.